These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 8233748

  • 1. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
    Molta C, Meyer O, Dosquet C, Montes de Oca M, Babron MC, Danon F, Kaplan C, Clémenceau S, Castellano F, Levy M.
    Pediatrics; 1993 Dec; 92(6):849-53. PubMed ID: 8233748
    [Abstract] [Full Text] [Related]

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 3. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
    Seaman DE, Londino AV, Kwoh CK, Medsger TA, Manzi S.
    Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
    [Abstract] [Full Text] [Related]

  • 4. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 6. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 7. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J, Cabral AR, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [Abstract] [Full Text] [Related]

  • 8. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR, Wang GS, Sharp GC, Hoffman RW.
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM.
    Arthritis Rheum; 2009 Jan 15; 61(1):29-36. PubMed ID: 19116963
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
    Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DM, Salmon JE.
    Arthritis Rheum; 2006 Dec 15; 54(12):3918-25. PubMed ID: 17133599
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M.
    J Rheumatol; 1998 Apr 15; 25(4):675-80. PubMed ID: 9558168
    [Abstract] [Full Text] [Related]

  • 18. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun 15; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 19. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct 15; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct 15; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.